Rosiglitazone and carotid IMT progression rate in a mixed cohort of patients with type 2 diabetes and the insulin resistance syndrome: main results from the Rosiglitazone Atherosclerosis Study

✍ Scribed by B. Hedblad; A. Zambanini; P. Nilsson; L. Janzon; G. Berglund

• Book ID: 108862316
• Publisher: John Wiley and Sons
• Year: 2007
• Tongue: English
• Weight: 583 KB
• Volume: 261
• Category: Article
• ISSN: 0954-6820
• DOI: 10.1111/j.1365-2796.2007.01767.x